Avila M A, Mingorance J, Martínez-Chantar M L, Casado M, Martin-Sanz P, Boscá L, Mato J M
Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas, Facultad de Farmacia, Madrid, Spain.
Hepatology. 1997 Feb;25(2):391-6. doi: 10.1002/hep.510250222.
We investigated the modulation of rat liver S-adenosylmethionine (SAM) synthetase in a model of acute sepsis. Our results show that animals treated with bacterial lipopolysaccharide experience a marked decrease in liver SAM synthetase activity. No changes were detected in the hepatic levels of SAM synthetase protein, suggesting that inactivation of the existing enzyme was the cause of the observed activity loss. Lipopolysaccharide treatment resulted in the expression of calcium-independent/cytokine-inducible nitric oxide (NO) synthase in liver and the accumulation in plasma of the NO-derived species nitrite and nitrate. NO implication in the in vivo regulation of SAM synthetase was evaluated in animals treated with the NO donor molecule 3-morpholinosydnonimine. The analysis of liver enzymatic activity, along with protein and messenger RNA levels yielded results similar to those obtained with lipopolysaccharide treatment. To assess directly the sensitivity of SAM synthetase to NO, the rat liver-purified high- and low-molecular weight forms of the enzyme were exposed to various doses of 3-morpholinosydnonimine and other NO donors such as S-nitroso-N-acetylpenicillamine, resulting in a dose-dependent inhibition of enzymatic activity. This effect was reversed by addition of the reducing agents beta-mercaptoethanol and glutathione. Finally, cysteine 121 was identified as the site of molecular interaction between NO and rat liver SAM synthetase that is responsible for the inhibition of the enzyme. To reach this conclusion, the 10 cysteine residues of the enzyme were changed to serine by site-directed mutagenesis, and the effect of NO on the various recombinant enzymes was measured.
我们在急性脓毒症模型中研究了大鼠肝脏S-腺苷甲硫氨酸(SAM)合成酶的调节情况。我们的结果表明,用细菌脂多糖处理的动物肝脏SAM合成酶活性显著降低。未检测到肝脏中SAM合成酶蛋白水平的变化,这表明现有酶的失活是观察到的活性丧失的原因。脂多糖处理导致肝脏中钙非依赖性/细胞因子诱导型一氧化氮(NO)合酶的表达以及血浆中NO衍生物质亚硝酸盐和硝酸盐的积累。在用NO供体分子3-吗啉代辛二亚胺处理的动物中评估了NO对SAM合成酶体内调节的影响。对肝脏酶活性以及蛋白质和信使RNA水平的分析得出的结果与脂多糖处理获得的结果相似。为了直接评估SAM合成酶对NO的敏感性,将大鼠肝脏纯化的高分子量和低分子量形式的该酶暴露于不同剂量的3-吗啉代辛二亚胺和其他NO供体,如S-亚硝基-N-乙酰青霉胺,导致酶活性呈剂量依赖性抑制。加入还原剂β-巯基乙醇和谷胱甘肽可逆转这种作用。最后,半胱氨酸121被确定为NO与大鼠肝脏SAM合成酶之间分子相互作用的位点,该相互作用导致酶的抑制。为了得出这一结论,通过定点诱变将该酶的10个半胱氨酸残基变为丝氨酸,并测量了NO对各种重组酶的影响。